L&K Biomed Ltd. (KOSDAQ:156100)

L&K Biomed Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 19, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	302,441	132,181	202,956	107,379	143,972	505,923
Market Cap Growth	124.08%	-34.87%	89.01%	-25.42%	-71.54%	592.81%
Enterprise Value	308,170	129,243	200,512	115,624	150,234	520,503
Last Close Price	14380.00	6630.00	10180.00	7212.36	9679.51	35296.46
PE Ratio	54.17	13.57	-	-	-	-
Forward PE	-	25.02	25.02	25.02	25.02	25.02
PS Ratio	7.50	3.66	6.79	5.43	9.37	26.14
PB Ratio	7.09	3.67	6.64	9.98	5.81	14.81
P/TBV Ratio	6.35	3.19	5.87	9.29	6.19	16.57
EV/Sales Ratio	7.64	3.58	6.71	5.85	9.77	26.89
EV/EBITDA Ratio	58.72	22.88	46.12	-	-	-
EV/EBIT Ratio	124.10	41.99	98.58	-	-	-
Debt / Equity Ratio	0.52	0.65	0.44	2.34	0.91	0.59
Debt / EBITDA Ratio	4.23	4.14	3.11	-	-	-
Asset Turnover	0.50	0.50	0.52	0.35	0.26	0.30
Inventory Turnover	0.28	0.27	0.24	0.33	0.48	0.31
Quick Ratio	0.86	0.90	1.04	0.50	1.70	0.59
Current Ratio	1.86	1.63	1.95	0.95	3.01	1.63
Return on Equity (ROE)	14.33%	27.47%	-25.34%	-91.33%	-46.30%	-30.56%
Return on Assets (ROA)	1.93%	2.64%	2.20%	-14.22%	-16.15%	-3.69%
Return on Capital (ROIC)	2.59%	3.72%	3.18%	-19.14%	-18.84%	-4.16%
Return on Capital Employed (ROCE)	5.00%	7.00%	5.10%	-86.80%	-32.70%	-9.80%
Earnings Yield	1.93%	7.37%	-0.92%	-12.69%	-6.72%	-2.12%
FCF Yield	-4.42%	-6.06%	-1.68%	-6.22%	-7.29%	-0.54%
Buyback Yield / Dilution	-8.24%	-32.67%	-21.04%	-0.07%	-12.57%	-14.15%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.